Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

229.31 +0.82 (+0.36%)

Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

91 92 Next >

Recent Report Shows That Rep. Jefferson Shreve Bought Up to $4.75M Worth of Apple Stock ↗

May 09, 2025

Via Benzinga

Thursday's session: gap up and gap down stock in the S&P500 index ↗

May 08, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks

May 07, 2025

Let’s dig into the relative performance of AbbVie (NYSE:ABBV) and its peers as we unravel the now-completed Q1 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

This House of Representative Just Bought Up To $915K In AbbVie Stock ↗

May 07, 2025

Via Benzinga

AbbVie's Options Frenzy: What You Need to Know ↗

April 28, 2025

Via Benzinga

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought ↗

May 07, 2025

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Via Benzinga

Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns ↗

May 06, 2025

President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new...

Via Benzinga

Topics Government World Trade

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar

May 06, 2025

"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their...

Via StockStory

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? ↗

May 05, 2025

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases.

Via Benzinga

Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now ↗

May 05, 2025

Via The Motley Fool

Topics Government Stocks World Trade

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? ↗

May 04, 2025

Via The Motley Fool

Topics Earnings Economy Government

Invest in These ETFs to Prepare Your Portfolio for a Recession ↗

May 03, 2025

Being prepared is important

Via The Motley Fool

Topics ETFs Economy

Benzinga Bulls And Bears: Lilly, Microsoft, Starbucks — And Markets Fully Recover Tariff Chaos Losses ↗

May 03, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

May 02, 2025

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

Via MarketBeat

Topics Economy World Trade

8 Health Care Stocks Whale Activity In Today's Session ↗

May 01, 2025

Via Benzinga

Netflix, Sherwin-Williams, AbbVie And More On CNBC's 'Final Trades' ↗

April 30, 2025

Via Benzinga

AbbVie Scores FDA Approval For Its Blockbuster Drug Rinvoq To Treat Type Of Arthritis ↗

April 29, 2025

AbbVie wins FDA approval for Rinvoq in giant cell arteritis after strong Phase 3 results and a 57.2% year-over-year sales increase in Q1.

Via Benzinga

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years ↗

April 29, 2025

Via Benzinga

Stock Of The Day: AbbVie's Rally Looks Stretched — Could A Reversal Be Next? ↗

April 29, 2025

Shares of AbbVie (ABBV) have gained more than 12% in the past week. But now they are overbought and may reverse.

Via Benzinga

US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week ↗

April 29, 2025

U.S. stock futures are trading flat on Tuesday early-morning, keeping with the broad index averages on Monday, as markets await clarity and more earnings reports to come in over the course of this...

Via Benzinga

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

April 29, 2025

Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings tomorrow morning. Here’s what to look for.

Via StockStory

Topics Government World Trade

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

Why AbbVie Stock Trounced the Market Today ↗

April 28, 2025

Via The Motley Fool

These S&P500 stocks are moving in today's session ↗

April 28, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst ↗

April 28, 2025

Analysts raise AbbVie price targets after strong Q1 results, driven by Skyrizi, Rinvoq growth and strategic moves in Parkinson's disease treatments.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

April 28, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

3 Dividend Stocks to Buy and Hold for the Next Decade ↗

April 28, 2025

Via The Motley Fool

US Stock Futures Fall As Markets Brace For Earnings From Microsoft, Meta, Apple And Apple This Week: 'Earnings Estimates Don't Signal A Recession' Says Leading Analyst ↗

April 28, 2025

U.S. stock futures are down in early-morning trade on Monday, after ending the previous week on a high note, with back-to-back sessions of strong rallies.

Via Benzinga

Should Investors Be Worried About Dividend King AbbVie? ↗

April 28, 2025

Via The Motley Fool

Topics Earnings Government World Trade

Incyte (INCY) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Government World Trade

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

91 92 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AbbVie (NY:ABBV)

All News about AbbVie

Starting at $3.75/week.

Subscribe Today